Development of an internally controlled real-time reverse transcriptase PCR assay for pan-dengue virus detection and comparison of four molecular dengue virus detection assays

Journal of Clinical Microbiology

Volumn 51, Issue 7, 2013, Pages 2172-2181

  Waggoner, Jesse J ^a   Abeynayake, Janaki ^a   Sahoo, Malaya K ^a   Gresh, Lionel ^b   Tellez, Yolanda ^c   Gonzalez, Karla ^c   Ballesteros, Gabriela ^c   Balmaseda, Angel ^c   Karunaratne, Kumudu ^d   Harris, Eva ^e   Pinsky, Benjamin A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Sustainable Sciences Institute   (Nicaragua)

^c Ministry of Health   (Nicaragua)

^d Lady Ridgeway Hospital   (Sri Lanka)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA;

5' UNTRANSLATED REGION; ALTONA ASSAY; ARTICLE; ASSAY; BRASSICA RAPA; CONTROLLED STUDY; DENGUE VIRUS; DIAGNOSTIC TEST ACCURACY STUDY; INTERMETHOD COMPARISON; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MOLECULAR DIAGNOSIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCHISTOSOMA MANSONI; SENSITIVITY AND SPECIFICITY; SEROTYPE; VIRUS CULTURE; VIRUS DETECTION; VIRUS LOAD; COHORT ANALYSIS; COMPARATIVE STUDY; DENGUE; EVALUATION STUDY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; NICARAGUA; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SRI LANKA; STANDARD; STANDARDS; VIROLOGY;

DENGUE VIRUS;

COHORT STUDIES; DENGUE; DENGUE VIRUS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; NICARAGUA; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE STANDARDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SRI LANKA;

EID: 84879454509     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00548-13     Document Type: Article

References (50)

1. World Health Organization. 2009. Dengue: guidelines for diagnosis, treatment, prevention and control. WHO Press, Geneva, Switzerland.
2. World Health Organization. 1997. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control, 2nd ed. World Health Organization, Geneva, Switzerland.
3. Halstead SB, Nimmannitya S, Cohen SN. 1970. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J. Biol. Med. 42:311-328.
4. Martina BEE, Koraka P, Osterhaus AD. 2009. Dengue virus pathogenesis: an integrated view. Clin. Microbiol. Rev. 22:564-581.
5. Gubler DJ. 2012. The economic burden of dengue. Am. J. Trop. Med. Hyg. 86:743-744.
6. Beatty ME, Letson GW, Margolis HS. 2008. Estimating the global burden of dengue. In Abstract book: dengue 2008. Proceedings of the 2nd International Conference on Dengue and Dengue Haemorrhagic Fever. Phuket, Thailand.
7. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, Keystone JS, Pandey P, Cetron MS, GeoSentinel Surveillance Network. 2006. Spectrum of disease and relation to place of exposure among ill returned travelers. N. Engl. J. Med. 354:119-130.
8. Burnette WN, Hoke CH, Jr, Scovill J, Clark K, Abrams J, Kitchen LW, Hanson K, Palys TJ, Vaughn DW. 2008. Infectious disease investment decision evaluation algorithm: a quantitative algorithm for prioritization of naturally occurring infectious disease threats to the U.S. military. Mil. Med. 173:174-181.
9. Flores-Figueroa J, Okhuysen PC, von Sonnenburg F, DuPont HL, Libman MD, Keystone JS, Hale DC, Burchard G, Han PV, Wilder-Smith A, Freedman DO, GeoSentinel Surveillance Network. 2011. Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience. Clin. Infect. Dis. 53:523-531.
10. Peeling RW, Artsob H, Pelegrino JL, Buchy P, Cardosa MJ, Devi S, Enria DA, Farrar J, Gubler DJ, Guzman MG, Halstead SB, Hunsperger E, Kliks S, Margolis HS, Nathanson CM, Nguyen VC, Rizzo N, Vázquez S, Yoksan S. 2010. Evaluation of diagnostic tests: dengue. Nat. Rev. Microbiol. 8(12 Suppl):S30-S38. doi:10.1038/nrmicro2459.
11. Chien LJ, Liao TL, Shu PY, Huang JH, Gubler DJ, Chang GJJ. 2006. Development of real-time reverse transcriptase PCR assays to detect and serotype dengue viruses. J. Clin. Microbiol. 44:1295-1304.
12. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. 1992. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J. Clin. Microbiol. 30:545-551.
13. Johnson BW, Russell BJ, Lanciotti RS. 2005. Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay. J. Clin. Microbiol. 43:4977-4983.
14. Muñoz-Jordán J, Collins CS, Vergne E, Santiago GA, Peterson L, Sun W, Linnen JM. 2009. Highly sensitive detection of dengue virus nucleic acid in samples from clinically ill patients. J. Clin. Microbiol. 47:927-931.
15. Ito M, Takasaki T, Yamada KI, Nerome R, Tajima S, Kurane I. 2004. Development and evaluation of fluorogenic TaqMan reverse transcriptase PCR assays for detection of dengue virus types 1 to 4. J. Clin. Microbiol. 42:5935-5937.
16. Waggoner J, Abeynayake J, Sahoo MK, Gresh L, Tellez Y, Gonzalez K, Ballesteros G, Pierro AM, Gaibani P, Guo FP, Sambri V, Balmaseda A, Karunarante K, Harris E, Pinsky BA. 2013. Single-reaction, multiplex, real-time RT-PCR for the detection, quantitation, and serotyping of dengue viruses. PLoS Negl. Trop. Dis. 7:e2116. doi:10.1371/journal.pntd.0002116.
17. Harris E, Roberts TG, Smith L, Selle J, Kramer LD, Valle S, Sandoval E, Balmaseda A. 1998. Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR. J. Clin. Microbiol. 36:2634-2639.
18. Callahan JD, Wu SJ, Dion-Schultz A, Mangold BE, Peruski LF, Watts DM, Porter KR, Murphy GR, Suharyono W, King CC, Hayes CG, Temenak JJ. 2001. Development and evaluation of serotype-and groupspecific fluorogenic reverse transcriptase PCR (TaqMan) assays for dengue virus. J. Clin. Microbiol. 39:4119-4124.
19. Drosten C, Göttig S, Schilling S, Asper M, Panning M, Schmitz H, Günther S. 2002. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J. Clin. Microbiol. 40:2323-2330.
20. Dumoulin A, Marti H, Panning M, Hatz C, Hirsch HH. 2008. Pandengue virus detection by PCR for travelers returning from the tropics. J. Clin. Microbiol. 46:3104-3106.
21. Hue KD, Tuan TV, Thi HT, Bich CT, Anh HH, Wills BA, Simmons CP. 2011. Validation of an internally controlled one-step real-time multiplex RT-PCR assay for the detection and quantitation of dengue virus RNA in plasma. J. Virol. Methods 177:168-173.
22. Kong YY, Thay CH, Tin TC, Devi S. 2006. Rapid detection, serotyping and quantitation of dengue viruses by TaqMan real-time one-step RTPCR. J. Virol. Methods 138:123.
23. Lai Y, Chung YK, Tan HC, Yap HF, Yap G, Ooi EE, Ng LC. 2007. Cost-effective real-time reverse transcriptase PCR (RT-PCR) to screen for Dengue virus followed by rapid single-tube multiplex RT-PCR for serotyping of the virus. J. Clin. Microbiol. 45:935-941.
24. Leparc-Goffart I, Baragatti M, Temmam S, Tuiskunen A, Moureau G, Charrel R, de Lamballerie X. 2009. Development and validation of realtime one-step reverse transcription-PCR for the detection and typing of dengue viruses. J. Clin. Virol. 45:61-66.
25. Naze F, Le Roux K, Schuffenecker I, Zeller H, Staikowsky F, Grivard P, Michault A, Laurent P. 2009. Simultaneous detection and quantitation of Chikungunya, Dengue and West Nile viruses by multiplex RT-PCR assays and Dengue virus typing using high resolution melting. J. Virol. Methods 162:1-7.
26. Domingo C, Niedrig M, Teichmann A, Kaiser M, Rumer L, Jarman RG, Donoso-Mantke O. 2010. 2nd international external quality control assessment for the molecular diagnosis of Dengue infections. PLoS Negl. Trop. Dis. 4:e833. doi:10.1371/journal.pntd.0000833.
27. Duyen HT, Ngoc TV, Ha do T, Hang VT, Kieu NT, Young PR, Farrar JJ, Simmons CP, Wolbers M, Wills BA. 2011. Kinetics of plasma viremia and soluble nonstructural protein 1 concentrations in dengue: differential effects according to serotype and immune status. J. Infect. Dis. 203:1292-1300.
28. Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, Vaughn DW, Nisalak A, Ennis FA, Rothman AL. 2002. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J. Infect. Dis. 186:1165-1168.
29. Tricou V, Minh NN, Farrar J, Tran HT, Simmons CP. 2011. Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue. PLoS Negl. Trop. Dis. 5:e1309. doi:10.1371/journal.pntd. 0001309.
30. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, Nisalak A. 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181:2-9.
31. Wang WK, Lee CN, Kao CL, Lin YL, King CC. 2000. Quantitative competitive reverse transcription-PCR for quantification of dengue virus RNA. J. Clin. Microbiol. 38:3306-3310.
32. Burd EM. 2010. Validation of laboratory-developed molecular assays for infectious diseases. Clin. Microbiol. Rev. 23:550-576.
33. WHO/CDC. 2009. CDC protocol of realtime RTPCR for swine influenza A (H1N1). WHO Collaborating Centre for Influenza at CDC Atlanta, United States of America, Atlanta, GA.
34. Rossini G, Carletti F, Bordi L, Cavrini F, Gaibani P, Landini MP, Pierro A, Capobianchi MR, Di Caro A, Sambri V. 2011. Phylogenetic analysis of West Nile virus isolates, Italy, 2008-2009. Emerg. Infect. Dis. 17:903-906.
35. Gutierrez G, Standish K, Narvaez F, Perez MA, Saborio S, Elizondo D, Ortega O, Nuñez A, Kuan G, Balmaseda A, Harris E. 2011. Unusual dengue virus 3 epidemic in Nicaragua, 2009. PLoS Negl. Trop. Dis. 5:e1394. doi:10.1371/journal.pntd.0001394.
36. Kuan G, Gordon A, Avilés W, Ortega O, Hammond SN, Elizondo D, Nuñez A, Coloma J, Balmaseda A, Harris E. 2009. The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases. Am. J. Epidemiol. 170:120-129.
37. Narvaez F, Gutierrez G, Pérez MA, Elizondo D, Nuñez A, Balmaseda A, Harris E. 2011. Evaluation of the traditional and revised WHO classifications of Dengue disease severity. PLoS Negl. Trop. Dis. 5:e1397. doi:10.1371/journal.pntd.0001397.
38. Raengsakulrach B, Nisalak A, Maneekarn N, Yenchitsomanus PT, Lim-somwong C, Jairungsri A, Thirawuth V, Green S, Kalayanarooj S, Suntayakorn S, Sittisombut N, Malasit P, Vaughn D. 2002. Comparison of four reverse transcription-polymerase chain reaction procedures for the detection of dengue virus in clinical specimens. J. Virol. Methods 105:219-232.
39. Yamada K, Takasaki T, Nawa M, Kurane I. 2002. Virus isolation as one of the diagnostic methods for dengue virus infection. J. Clin. Virol. 24: 203-209.
40. Dos Santos HW, Poloni TR, Souza KP, Muller VD, Tremeschin F, Nali LC, Fantinatti LR, Amarilla AA, Castro HL, Nunes MR, Casseb SM, Vasconcelos PF, Badra SJ, Figueiredo LT, Aquino VH. 2008. A simple one-step real-time RT-PCR for diagnosis of dengue virus infection. J. Med. Virol. 80:1426-1433.
41. Chutinimitkul S, Payungporn S, Theamboonlers A, Poovorawan Y. 2005. Dengue typing assay based on real-time PCR using SYBR Green I. J. Virol. Methods 129:8-15.
42. Gurukumar KR, Priyadarshini D, Patil JA, Bhagat A, Singh A, Shah PS, Cecilia D. 2009. Development of real time PCR for detection and quantitation of dengue viruses. Virol. J. 6:10. doi:10.1186/1743-422X-6-10.
43. Hertz JT, Munishi OM, Ooi EE, Howe S, Lim WY, Chow A, Morrissey AB, Bartlett JA, Onyango JJ, Maro VP, Kinabo GD, Saganda W, Gubler DJ, Crump JA. 2012. Chikungunya and dengue fever among hospitalized febrile patients in northern Tanzania. Am. J. Trop. Med. Hyg. 86:171-177.
44. Laue T, Emmerich P, Schmitz H. 1999. Detection of dengue virus RNA in patients after primary or secondary dengue infection by using the Taq-Man automated amplification system. J. Clin. Microbiol. 37:2543-2547.
45. Shu PY, Chang SF, Kuo YC, Yueh YY, Chien LJ, Sue CL, Lin TH, Huang JH. 2003. Development of group-and serotype-specific one-step SYBR green I-based real-time reverse transcription-PCR assay for dengue virus. J. Clin. Microbiol. 41:2408-2416.
46. Balmaseda A, Standish K, Mercado JC, Matute JC, Tellez Y, Saborio S, Hammond SN, Nuñez A, Avilés W, Henn MR, Holmes EC, Gordon A, Coloma J, Kuan G, Harris E. 2010. Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. J. Infect. Dis. 201:5-14.
47. Endy TP, Anderson KB, Nisalak A, Yoon IK, Green S, Rothman AL, Thomas SJ, Jarman RG, Libraty DH, Gibbons RV. 2011. Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand. PLoS Negl. Trop. Dis. 5:e975. doi:10.1371/journal. pntd.0000975.
48. Endy TP, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, Rothman AL, Vaughn DW, Ennis FA. 2002. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am. J. Epidemiol. 156:40-51.
49. Standish K, Kuan G, Avilés W, Balmaseda A, Harris E. 2010. High dengue case capture rate in four years of a cohort study in Nicaragua compared to national surveillance data. PLoS Negl. Trop. Dis. 4:e633. doi: 10.1371/journal.pntd.0000633.
50. Kutyavin IV, Afonina IA, Mills A, Gorn VV, Lukhtanov EA, Belousov ES, Singer MJ, Walburger DK, Lokhov SG, Gall AA, Dempcy R, Reed MW, Meyer RB, Hedgpeth J. 2000. 3=-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res. 28:655-661.